DRUG

MEK inhibitors

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for MEK inhibitors

Rheumatoid arthritis 1

Mediator Outcome Score Tier Lit. status Trial
STAT3 prurigo nodularis 0.208 Mid novel signal none

Clinical trials

46 registered trials for MEK inhibitors

Source: ClinicalTrials.gov

← All drugs